Immunic | VTL - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
BioMarin Pharmaceutical USD 571.21M 141.8M 2026-03
Cipla INR 39.1B 2.54B 2026-03
Clal Biotechnology ILS -857K 1.42M 2022-06
Compugen USD 352K 63.44M 2026-03
CSL USD 4.46B 2.71B 2025-12
Enanta Pharmaceuticals -22.29M 23.75M 2024-12
Grifols EUR 766.49M 39.74M 2024-12
Immunic 0 0 2025-03
Insmed USD 256.46M 38.78M 2026-03
Omeros USD -33.16M 18.52M 2024-06
OraSure Technologies USD 11.34M 435K 2025-12
Quidel USD -91.8M 366.6M 2026-03
Ultragenyx Pharmaceutical USD 106M 72M 2026-03
United Therapeutics USD 315.5M 286.6M 2025-12
Xoma 992K 846K 2024-06